B lymphocytes and CD4+ and CD8+ T lymphocytes were reported to be reduced in severely ill and critically ill COVID-19 patients, which could be related to patient outcomes (Sun et al., 2020; Huang et al., 2020). The gene discussed is CD8A; the disease is COVID-19.